|Original Press release|
Chemir Analytical Services
2672 Metro Blvd.
Maryland Heights, MO, 63043
New Addition to Chemir's Pharmaceutical Division
September 19, 2006, St. Louis, MO - Chemir Analytical Services is proud to announce the hiring of Lawrence (Bob) R. Lima III, Ph.D, as Vice President - Pharmaceutical Services. Dr. Lima directs the growing drug development services of Chemir's Maryland Heights facility. "The pharmaceutical and medical device industries have long utilized our analytical and research capabilities, and about half of our work is pharma-related," says David Dowell, Ph.D., President of Chemir Analytical Services. "We welcome Bob's depth of knowledge and experience in maintaining GMP compliance in FDA regulated studies as we further expand our service offerings to the pharma industry."
Lima formerly directed analytical services at Analytical Biochemistry (ABC) Laboratories, as well as managed drug development projects for Allergan Pharmaceuticals and Procter & Gamble Pharmaceuticals. He earned a Ph.D. in Analytical Chemistry from the University of Washington.
The Chemir group of companies began with the purchase of a 2-chemist operation by Shri Thanedar in 1990. Today the company has over 100 employees, four divisions, with expansion fueled by steady internal growth and well-timed acquisitions. The Chemir group of services includes:
o Chemir Analytical Services- Non-routine industrial problem solving, drug development services & product testing
o Azopharma Contract Pharmaceutical Services- Contract pharmaceutical services
o IQsynthesis- Custom synthesis and process development
o CAS-MI- Paints, coatings, and polymers experts
Sales are expected to reach $24 million in 2006, with anticipated goal of $50 million by 2009.
Shri Thanedar, Ph.D.,
CEO, Chemir Analytical Services,
2672 Metro Blvd.,
Maryland Heights MO 63043,